D.E. Shaw & Co’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-335,290
| Closed | -$5.03M | – | 3541 |
|
2022
Q4 | $5.03M | Sell |
335,290
-129,356
| -28% | -$1.94M | 0.01% | 1456 |
|
2022
Q3 | $5.48M | Buy |
464,646
+117,192
| +34% | +$1.38M | 0.01% | 1376 |
|
2022
Q2 | $3.93M | Buy |
347,454
+294,081
| +551% | +$3.32M | ﹤0.01% | 1778 |
|
2022
Q1 | $1.6M | Buy |
53,373
+45,144
| +549% | +$1.35M | ﹤0.01% | 2583 |
|
2021
Q4 | $218K | Sell |
8,229
-4,666
| -36% | -$124K | ﹤0.01% | 3450 |
|
2021
Q3 | $468K | Buy |
+12,895
| New | +$468K | ﹤0.01% | 2875 |
|
2021
Q1 | – | Sell |
-4,667
| Closed | -$163K | – | 3153 |
|
2020
Q4 | $163K | Sell |
4,667
-9,299
| -67% | -$325K | ﹤0.01% | 2592 |
|
2020
Q3 | $335K | Sell |
13,966
-86,975
| -86% | -$2.09M | ﹤0.01% | 2241 |
|
2020
Q2 | $1.85M | Buy |
100,941
+60,525
| +150% | +$1.11M | ﹤0.01% | 1647 |
|
2020
Q1 | $630K | Sell |
40,416
-3,981
| -9% | -$62.1K | ﹤0.01% | 2060 |
|
2019
Q4 | $950K | Sell |
44,397
-9,965
| -18% | -$213K | ﹤0.01% | 1942 |
|
2019
Q3 | $1.02M | Buy |
54,362
+29,306
| +117% | +$548K | ﹤0.01% | 1848 |
|
2019
Q2 | $654K | Buy |
25,056
+15,953
| +175% | +$416K | ﹤0.01% | 2045 |
|
2019
Q1 | $234K | Sell |
9,103
-2,228
| -20% | -$57.3K | ﹤0.01% | 2339 |
|
2018
Q4 | $261K | Sell |
11,331
-12,048
| -52% | -$278K | ﹤0.01% | 2301 |
|
2018
Q3 | $750K | Sell |
23,379
-41,017
| -64% | -$1.32M | ﹤0.01% | 1926 |
|
2018
Q2 | $1.82M | Sell |
64,396
-17,808
| -22% | -$504K | ﹤0.01% | 1634 |
|
2018
Q1 | $2.91M | Sell |
82,204
-73,639
| -47% | -$2.61M | ﹤0.01% | 1320 |
|
2017
Q4 | $6.05M | Buy |
155,843
+4,723
| +3% | +$183K | 0.01% | 987 |
|
2017
Q3 | $3.84M | Buy |
151,120
+15,591
| +12% | +$396K | 0.01% | 1162 |
|
2017
Q2 | $3.7M | Sell |
135,529
-26,336
| -16% | -$719K | 0.01% | 1152 |
|
2017
Q1 | $5.36M | Buy |
161,865
+16,349
| +11% | +$541K | 0.01% | 954 |
|
2016
Q4 | $3.46M | Sell |
145,516
-46,663
| -24% | -$1.11M | 0.01% | 1122 |
|
2016
Q3 | $7.05M | Sell |
192,179
-49,836
| -21% | -$1.83M | 0.01% | 807 |
|
2016
Q2 | $5.4M | Sell |
242,015
-14,471
| -6% | -$323K | 0.01% | 941 |
|
2016
Q1 | $5.34M | Buy |
256,486
+12,486
| +5% | +$260K | 0.01% | 935 |
|
2015
Q4 | $7.39M | Buy |
244,000
+14,650
| +6% | +$444K | 0.01% | 780 |
|
2015
Q3 | $5.67M | Buy |
229,350
+4,877
| +2% | +$120K | 0.01% | 874 |
|
2015
Q2 | $7.21M | Buy |
224,473
+16,875
| +8% | +$542K | 0.01% | 852 |
|
2015
Q1 | $7.41M | Buy |
207,598
+51,866
| +33% | +$1.85M | 0.01% | 796 |
|
2014
Q4 | $3.54M | Buy |
155,732
+4,598
| +3% | +$104K | ﹤0.01% | 1088 |
|
2014
Q3 | $2.93M | Sell |
151,134
-14,315
| -9% | -$278K | ﹤0.01% | 1071 |
|
2014
Q2 | $6.01M | Buy |
165,449
+3,175
| +2% | +$115K | 0.01% | 835 |
|
2014
Q1 | $6.3M | Buy |
162,274
+13,064
| +9% | +$507K | 0.01% | 793 |
|
2013
Q4 | $4.25M | Buy |
149,210
+39,664
| +36% | +$1.13M | 0.01% | 941 |
|
2013
Q3 | $3.92M | Buy |
109,546
+26,702
| +32% | +$956K | 0.01% | 960 |
|
2013
Q2 | $2.77M | Buy |
+82,844
| New | +$2.77M | 0.01% | 1035 |
|